Monday, September 22, 2014

Clinical Ink's eSouce Platform Selected to Power Global Central Nervous System Study

Clinical Ink's SureSource(R) Platform Will Provide Real-Time Data Capture and Remote Monitoring for Phase II Alzheimer's Clinical Trial




Clinical Ink's eSouce Platform Selected to Power Global Central Nervous System Study

No comments:

Post a Comment